Search - tctmd.com

Displaying 121 - 140 of 654

Sort: Relevancy | Date

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Predictors of Device-Related Thrombus Following LAA Occlusion

Shelley Wood

July 19, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News Daily News

FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk

Michael O'Riordan

June 30, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Yael L. Maxwell

May 26, 2021

News Conference News ACC 2021

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI

Yael L. Maxwell

May 17, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

News Daily News

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Todd Neale

May 14, 2021

News Industry News

Essentials of Clinical Trial Design: Statistics 101 for the Budding Interventionalist

May 13, 2021

News Conference News SCAI 2021

Chinese Registry Supports Prolonged DAPT Following PCI for ACS

Yael L. Maxwell

May 03, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Daily News

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

Todd Neale

April 16, 2021

News Daily News

Lean Antithrombotic Regimen Recommended After TAVI

Todd Neale

April 12, 2021

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Daily News

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

Shelley Wood

April 06, 2021

Advertisement

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Predictors of Device-Related Thrombus Following LAA Occlusion

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

TCTMD’s Top 10 Most Popular Stories for May 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Diabetes Duration and Meds Don’t Impact Ticagrelor Effects in THEMIS

Essentials of Clinical Trial Design: Statistics 101 for the Budding Interventionalist

Chinese Registry Supports Prolonged DAPT Following PCI for ACS

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Ticagrelor’s Dominance Over Clopidogrel Again Questioned

Lean Antithrombotic Regimen Recommended After TAVI

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content